KM Pharma Calls EGM for Article Amendments and Executive Compensation Rules


  • Board resolved to call an EGM on June 23, 2026; record date May 22, 2026
  • Agenda: amend articles (reflect commercial law changes, align compensation rules), approve new executive compensation regulations, amend executive severance pay regulations
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: KMPHARMACEUTICAL Co.,Ltd.
  • Receipt: 05-06-2026
  • Under KRX KOSDAQ Market Division